Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology

被引:335
作者
Harrison, Paul J. [1 ]
Law, Amanda J. [1 ]
机构
[1] Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England
基金
英国惠康基金;
关键词
neuregulin; gene; schizophrenia; mRNA; pathophysiology;
D O I
10.1016/j.biopsych.2005.11.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuregulin 1 (NRG1) is a leading schizophrenia susceptibility gene. The NRG1 locus on chromosome 8p shows linkage to, the disorder, and genetic association has been found between schizophrenia and various non-coding polymorphisms and haplotypes, especially at the 5' end of the NRG1 gene, in many but not all case-control and family studies. NRG1 is a pleiotropic growth factor, important in nervous system development and functioning; roles include the modulation of neuronal migration, synaptogenesis, gliogenesis, neuron-glia communication, myelination, and neurotransmission. Understanding the neurobiology of NRG1 and its involvement in schizophrenia is challenged by the complexity of the gene, which gives rise to multiple functionally distinct isoforms, including six "types" of NRG1 defined by 5 exon usage. Type IV and type I NRG1 may be particularly relevant to schizophrenia, with initial data showing altered expression of these isoforms in the disorder or in association with NRG1 risk alleles. We review the structure and functions of NRG1, consider the evidence for and against it being a schizophrenia susceptibility gene, and discuss mechanisms that might underlie the contribution of NRG1 to disease pathophysiology.
引用
收藏
页码:132 / 140
页数:9
相关论文
共 106 条
  • [11] Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
    Burden, S
    Yarden, Y
    [J]. NEURON, 1997, 18 (06) : 847 - 855
  • [12] ErbB-4: mechanism of action and biology
    Carpenter, G
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 66 - 77
  • [13] Neuregulin-1 and ErbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease
    Chaudhury, AR
    Gerecke, KM
    Wyss, JM
    Morgan, DG
    Gordon, MN
    Carroll, SL
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (01) : 42 - 54
  • [14] The deaf and the dumb: the biology of ErbB-2 and ErbB-3
    Citri, A
    Skaria, KB
    Yarden, Y
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 54 - 65
  • [15] Problems of reporting genetic associations with complex outcomes
    Colhoun, HM
    McKeigue, PM
    Smith, GD
    [J]. LANCET, 2003, 361 (9360) : 865 - 872
  • [16] Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
    Corfas, G
    Roy, K
    Buxbaum, J
    [J]. NATURE NEUROSCIENCE, 2004, 7 (06) : 575 - 580
  • [17] Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus
    Corvin, AP
    Morris, DW
    McGhee, K
    Schwaiger, S
    Scully, P
    Quinn, J
    Meagher, D
    St Clair, D
    Waddington, JL
    Gill, M
    [J]. MOLECULAR PSYCHIATRY, 2004, 9 (02) : 208 - 212
  • [18] Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia
    Coyle, JT
    Tsai, G
    Goff, D
    [J]. GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 : 318 - 327
  • [19] The beginning of the end for the Kraepelinian dichotomy
    Craddock, N
    Owen, MJ
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 : 364 - 366
  • [20] Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems
    Crone, SA
    Lee, KF
    [J]. CHROMAFFIN CELL: TRNSMITTER BIOSYNTHESIS, STORAGE, RELEASE, ACTIONS, AND INFORMATICS, 2002, 971 : 547 - 553